Divoux M, Plocque A, Sevin M, Voillat L, Feugier P, Guerci‐Bresler A, Girodon F, Broséus J. Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count.
Clin Case Rep 2020;
8:1774-1780. [PMID:
32983494 PMCID:
PMC7495870 DOI:
10.1002/ccr3.3026]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Revised: 04/24/2020] [Accepted: 05/10/2020] [Indexed: 11/06/2022] Open
Abstract
Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts.
Collapse